Although it is still not able to exclude the possibility that TRAIL treatment might induce other regulatory cells, such as MDSCs to regulate colitis, the results from adoptive transfer-induced colitis model clearly demonstrated TRAIL suppressed T cell activation and further prevented development of gut inflammation. Here, TNFSF10 is linked to colitis.